These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 22539788)

  • 1. Dendritic cell-specific ablation of the protein tyrosine phosphatase Shp1 promotes Th1 cell differentiation and induces autoimmunity.
    Kaneko T; Saito Y; Kotani T; Okazawa H; Iwamura H; Sato-Hashimoto M; Kanazawa Y; Takahashi S; Hiromura K; Kusakari S; Kaneko Y; Murata Y; Ohnishi H; Nojima Y; Takagishi K; Matozaki T
    J Immunol; 2012 Jun; 188(11):5397-407. PubMed ID: 22539788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B cell-specific deletion of protein-tyrosine phosphatase Shp1 promotes B-1a cell development and causes systemic autoimmunity.
    Pao LI; Lam KP; Henderson JM; Kutok JL; Alimzhanov M; Nitschke L; Thomas ML; Neel BG; Rajewsky K
    Immunity; 2007 Jul; 27(1):35-48. PubMed ID: 17600736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polarization of naive T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations: implications for immunotherapy.
    Feili-Hariri M; Falkner DH; Morel PA
    J Leukoc Biol; 2005 Sep; 78(3):656-64. PubMed ID: 15961574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The phosphatase SRC homology region 2 domain-containing phosphatase-1 is an intrinsic central regulator of dendritic cell function.
    Ramachandran IR; Song W; Lapteva N; Seethammagari M; Slawin KM; Spencer DM; Levitt JM
    J Immunol; 2011 Apr; 186(7):3934-45. PubMed ID: 21357539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-32gamma induces the maturation of dendritic cells with Th1- and Th17-polarizing ability through enhanced IL-12 and IL-6 production.
    Jung MY; Son MH; Kim SH; Cho D; Kim TS
    J Immunol; 2011 Jun; 186(12):6848-59. PubMed ID: 21551364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A minor population of splenic dendritic cells expressing CD19 mediates IDO-dependent T cell suppression via type I IFN signaling following B7 ligation.
    Baban B; Hansen AM; Chandler PR; Manlapat A; Bingaman A; Kahler DJ; Munn DH; Mellor AL
    Int Immunol; 2005 Jul; 17(7):909-19. PubMed ID: 15967784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of DC-STAMP in maintenance of immune tolerance through regulation of dendritic cell function.
    Sawatani Y; Miyamoto T; Nagai S; Maruya M; Imai J; Miyamoto K; Fujita N; Ninomiya K; Suzuki T; Iwasaki R; Toyama Y; Shinohara M; Koyasu S; Suda T
    Int Immunol; 2008 Oct; 20(10):1259-68. PubMed ID: 18653699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human dendritic cell (DC)-based anti-infective therapy: engineering DCs to secrete functional IFN-gamma and IL-12.
    Ahuja SS; Mummidi S; Malech HL; Ahuja SK
    J Immunol; 1998 Jul; 161(2):868-76. PubMed ID: 9670965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-regulation of CD86 by CD80 differentially regulates T helper responses from Mycobacterium tuberculosis secretory antigen-activated dendritic cell subsets.
    Balkhi MY; Latchumanan VK; Singh B; Sharma P; Natarajan K
    J Leukoc Biol; 2004 May; 75(5):874-83. PubMed ID: 14966193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outer membrane protein A of Acinetobacter baumannii induces differentiation of CD4+ T cells toward a Th1 polarizing phenotype through the activation of dendritic cells.
    Lee JS; Lee JC; Lee CM; Jung ID; Jeong YI; Seong EY; Chung HY; Park YM
    Biochem Pharmacol; 2007 Jun; 74(1):86-97. PubMed ID: 17482145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new subset of CD103+CD8alpha+ dendritic cells in the small intestine expresses TLR3, TLR7, and TLR9 and induces Th1 response and CTL activity.
    Fujimoto K; Karuppuchamy T; Takemura N; Shimohigoshi M; Machida T; Haseda Y; Aoshi T; Ishii KJ; Akira S; Uematsu S
    J Immunol; 2011 Jun; 186(11):6287-95. PubMed ID: 21525388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced cancer immunotherapy using STAT3-depleted dendritic cells with high Th1-inducing ability and resistance to cancer cell-derived inhibitory factors.
    Iwata-Kajihara T; Sumimoto H; Kawamura N; Ueda R; Takahashi T; Mizuguchi H; Miyagishi M; Takeda K; Kawakami Y
    J Immunol; 2011 Jul; 187(1):27-36. PubMed ID: 21632716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCL19 and CCL21 induce a potent proinflammatory differentiation program in licensed dendritic cells.
    Marsland BJ; Bättig P; Bauer M; Ruedl C; Lässing U; Beerli RR; Dietmeier K; Ivanova L; Pfister T; Vogt L; Nakano H; Nembrini C; Saudan P; Kopf M; Bachmann MF
    Immunity; 2005 Apr; 22(4):493-505. PubMed ID: 15845453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Splenic dendritic cells pulsed with Ixodes ricinus tick saliva prime naive CD4+T to induce Th2 cell differentiation in vitro and in vivo.
    Mejri N; Brossard M
    Int Immunol; 2007 Apr; 19(4):535-43. PubMed ID: 17344202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adiponectin induces dendritic cell activation via PLCγ/JNK/NF-κB pathways, leading to Th1 and Th17 polarization.
    Jung MY; Kim HS; Hong HJ; Youn BS; Kim TS
    J Immunol; 2012 Mar; 188(6):2592-601. PubMed ID: 22345647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cells are resistant to apoptosis through the Fas (CD95/APO-1) pathway.
    Ashany D; Savir A; Bhardwaj N; Elkon KB
    J Immunol; 1999 Nov; 163(10):5303-11. PubMed ID: 10553053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD8+ T cell responses following replication-defective adenovirus serotype 5 immunization are dependent on CD11c+ dendritic cells but show redundancy in their requirement of TLR and nucleotide-binding oligomerization domain-like receptor signaling.
    Lindsay RW; Darrah PA; Quinn KM; Wille-Reece U; Mattei LM; Iwasaki A; Kasturi SP; Pulendran B; Gall JG; Spies AG; Seder RA
    J Immunol; 2010 Aug; 185(3):1513-21. PubMed ID: 20610651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropeptide signaling activates dendritic cell-mediated type 1 immune responses through neurokinin-2 receptor.
    Kitamura H; Kobayashi M; Wakita D; Nishimura T
    J Immunol; 2012 May; 188(9):4200-8. PubMed ID: 22474018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dominance of CD86, transforming growth factor- beta 1, and interleukin-10 in Mycobacterium tuberculosis secretory antigen-activated dendritic cells regulates T helper 1 responses to mycobacterial antigens.
    Balkhi MY; Sinha A; Natarajan K
    J Infect Dis; 2004 May; 189(9):1598-609. PubMed ID: 15116295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of dendritic cell differentiation by vasoactive intestinal peptide: therapeutic applications on autoimmunity and transplantation.
    Chorny A; Gonzalez-Rey E; Delgado M
    Ann N Y Acad Sci; 2006 Nov; 1088():187-94. PubMed ID: 17192565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.